Concepts of CNS Plasticity in the Context of Brain Damage and Repair

  title={Concepts of CNS Plasticity in the Context of Brain Damage and Repair},
  author={Donald G. Stein and Stuart W. Hoffman},
  journal={Journal of Head Trauma Rehabilitation},
  • D. Stein, S. Hoffman
  • Published 1 July 2003
  • Medicine, Biology
  • Journal of Head Trauma Rehabilitation
Background:How effectively the brain can respond to injury and undergo structural repair has become one of the most exciting areas of contemporary basic and translational neuroscience research. Although there are no clinical treatments yet available to enhance repair of the damaged brain, there are a number of potential therapies being investigated. New drugs are designed to provide some degree of neuroprotection by preventing injured or vulnerable nerve cells from dying, or they are given in… 

Cellular and molecular neuronal plasticity.

Do children really recover better? Neurobehavioural plasticity after early brain insult.

It is concluded that neither plasticity nor vulnerability theories are able to explain the range of functional outcomes from early brain insult, and where a child's outcome falls along a 'recovery continuum' depends on injury factors and environmental influences.

Neuroplasticity in Brain Injury: Maximizing Recovery

The ability to promote greater neuroplasticity through external influencers is an emerging field of study with potentially significant consequences on the treatment of neurologic injury and novel approaches to promote neurorecovery that increase stimulation and the release of neutrophic factors are reviewed.

Animal Models of Traumatic Brain Injury: Is There an Optimal Model That Parallels Human Brain Injury?

  • T. L. Briones
  • Biology, Psychology
    Annual Review of Nursing Research
  • 2015
The failure to translate results from preclinical studies to the clinical setting underscores a compelling need to revisit the current state of knowledge in the use of animal models in TBI.

Substance P in traumatic brain injury.

The impact of enriched environment and transplantation of murine cortical embryonic stem cells on recovery from controlled cortical contusion injury.

Combing therapeutic strategies with enriching the post-injury environment is likely to be an important addition to determining the efficacy of pre-clinical therapies.

The injured nervous system: A Darwinian perspective

An analysis of poststroke motor dysfunction and cerebral reorganization in rats

Different mechanisms of plasticity in remaining cortical circuits are discussed as possible candidates responsible for the behavioural improvement and may stimulate research on therapies and possible mechanisms that might enhance recovery after stroke.

The role of Lysophosphatidic Acid in Traumatic Brain Injury outcomes

Two studies identified the spatial and temporal profile of LPA metabolism in the injured brain and associated those changes with markers of axonal injury (Beta-APP) and cell death (Fluro-JadeB) using MALDI mass spectrometry techniques and suggested that a one-time dose of Anti-LPA reduces axonal Injury and white matter inflammation but is insufficient on neuroprotection of the cortical grey matter.



Neuroprotection and traumatic brain injury: the search continues.

  • A. Faden
  • Biology, Psychology
    Archives of neurology
  • 2001
The conceptual and methodological issues that have contributed to the discrepancy between preclinical and clinical studies of traumatic brain injury are explored.

Pharmacotherapy for recovery of function after brain injury.

This article reviews both animal and human experimentation in two areas which appear to have considerable clinical applicability in the very near future for promoting recovery: drug manipulation of neurotransmitter systems and administration of gangliosides.

Role of adaptive plasticity in recovery of function after damage to motor cortex

These findings have strong clinical relevance as it has recently been shown that after injury to the motor cortex, as might occur in stroke, post‐injury behavioral experience may play an adaptive role in modifying the functional organization of the remaining, intact cortical tissue.

Current status of neuroprotection trials for traumatic brain injury: lessons from animal models and clinical studies.

Criteria for conducting clinical trials in severe traumatic brain injury, with suggestions for future improvements, is summarized and factors that might contribute to the discrepancies between animal and human trials are identified.

Brain Damage and Recovery: Research and Clinical Perspectives

The material, which may be unfamiliar to most readers, is organized in a thoughtful manner, and allows easy progress through the various anatomical, neurochemical, and physiological evidences of nervous system recovery.

Nogo-A, a Potent Inhibitor of Neurite Outgrowth and Regeneration

Nogo-A is a high molecular weight transmembrane protein and an antigen of the monoclonal antibody mAb IN-1 that was shown to promote long-distance regeneration and functional recovery in vivo when applied to spinal cord-injured adult rats.

Noradrenergic Pharmacotherapy, Intracerebral Infusion and Adrenal Transplantation Promote Functional Recovery After Cortical Damage

Evidence that short term pharmacological enhancement of noradrenergic (NA) synaptic activity, combined with symptom relevant experience (SRE), promotes functional recovery of some symptoms of cortical damage in rat, cat and human beings even when treatment is initiated from days to weeks after injury is summarized.

Neural features of recovery from CNS injury revealed by PET in human brain.

The present study suggests that initiation of reorganization of neural connections occurs in remote cortex in the aftermath of central nervous system injury, which appears to play a role in modulation of synaptic transmission in the intact brain.

Use-Dependent Exaggeration of Brain Injury: Is Glutamate Involved?

Administration of MK-801 during the casting period spared neural tissue surrounding the lesion and enhanced functional recovery of the impaired forelimb, suggesting a role for NMDA receptor-mediated processes in use-dependent exaggeration of injury.